Zobrazeno 1 - 8
of 8
pro vyhledávání: '"T P, Cooley"'
Autor:
L D, Kaplan, D J, Straus, M A, Testa, J, Von Roenn, B J, Dezube, T P, Cooley, B, Herndier, D W, Northfelt, J, Huang, A, Tulpule, A M, Levine
Publikováno v:
The New England journal of medicine. 336(23)
Reduced doses of cytotoxic chemotherapy or standard-dose therapy plus a myeloid colony-stimulating factor decreases hematologic toxicity and its complications in patients with non-Hodgkin's lymphoma associated with infection with the human immunodefi
Publikováno v:
AIDS (London, England). 10(11)
Objective : To describe the presentation and incidence of Kaposi's sarcoma (KS) in a cohort of women infected with HIV and to compare their clinical characteristics with men at the same institution. Design : Retrospective chart and database review. S
Autor:
M A, Wainberg, H, Salomon, Z, Gu, J S, Montaner, T P, Cooley, R, McCaffrey, J, Ruedy, H M, Hirst, N, Cammack, J, Cameron
Publikováno v:
AIDS (London, England). 9(4)
To determine the rate of development of in vitro HIV resistance to (-)2'-deoxy-3'-thiacytidine (3TC) and relate the effect of dose to emergence of resistance.HIV-infected men and non-pregnant women, agedor = 18 years, with a CD4 countor = 300 x 10(6)
Publikováno v:
Radiology. 193(2)
To evaluate the diagnostic specificity of thallium and gallium scan mismatch as a sign of mycobacterial infection in immunodeficient patients.Thallium and gallium scans obtained in 56 immunodeficient patients between January 1989 and March 1994 were
Autor:
Howard A. Liebman, T. P. Cooley, K. M. Devore, Joseph J. Eron, Joseph A. Videler, Angela M. Caliendo, Richard T. D'Aquila, Yung-Kang Chow, Joan C. Kaplan, M. S. Hirsch
Specific mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene that cause zidovudine (3'-azido-2',3'-dideoxythymidine; AZT) and didanosine (2',3'-dideoxyinosine; ddI) resistance were studied. The 50% inhibitory concentrations (IC50s)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d2314d7d5a4543da7613a535ef1abdd
https://europepmc.org/articles/PMC187998/
https://europepmc.org/articles/PMC187998/
Autor:
Howard A. Liebman, John S. Lambert, G Morse, Raphael Dolin, M Seidlin, George L. Drusano, T P Cooley, F T Valentine, Geoffrey J. Yuen
Publikováno v:
Antimicrobial agents and chemotherapy. 36(6)
The objective of this study was to determine the population pharmacokinetic parameters and the extent of absorption of 2',3'-dideoxyinosine, a nucleoside analog with activity against human immunodeficiency virus in vitro and in vivo, after oral and i
Publikováno v:
Cancer. 62(8)
Thirty patients with advanced non-small cell lung cancer (NSCLC) were treated with cisplatin (P), mitomycin C (M), and 5-fluorouracil (5-FU) chemotherapy. Twelve patients (40%) achieved major responses to therapy (11 partial, one regression). The med
Publikováno v:
SAE Technical Paper Series.